Efficacy of Group Exercise Program in Older People With Nonspecific Low Back Pain

Sponsor
Federal University of the Valleys of Jequitinhonha and Mucuri (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04915547
Collaborator
(none)
60
2
12

Study Details

Study Description

Brief Summary

The main objective of the study is to assess the feasibility of a randomized clinical trial that investigates the effects of an 8-week group exercise program on pain, disability, fear of falling, overall impression of recovery, frequency of falls and level of physical activity in elderly people with nonspecific low back pain.

Condition or Disease Intervention/Treatment Phase
  • Other: Group-Based Exercise
N/A

Detailed Description

The main objective of the study is to assess the feasibility of a randomized clinical trial that investigates the effects of an 8-week group exercise program on pain, disability, fear of falling, overall impression of recovery, frequency of falls and level of physical activity in elderly people with nonspecific low back pain. The evaluation of feasibility will be related to: (1) blinding the evaluator to allocate the groups; (2) eligibility and recruitment rates; (3) acceptability of random allocation to a group; (4) possible contamination between groups; (5) adherence to treatment; (6) satisfaction with the treatment; and (7) difficulty in understanding the information provided by the physiotherapist.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Efficacy of Group Exercise Program on Pain and Disability in Older People With Nonspecific Low Back Pain: Feasibility of a Randomized Controlled Trial.
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group-Based Exercise

The group-based exercise (GBE) programme will be delivered by a physiotherapist. The GBE comprises three sessions per week of group-based exercise in a local community centre, for 8 weeks.

Other: Group-Based Exercise
Each group session will consist of 10 to 18 participants and each exercise session will last 60 minutes and consist of four stages: (1) five minutes warm up (i.e. self-regulated walk); (2) twenty minutes of moderate intensity walking (3) thirty minutes of resistance training for the major muscles of the leg, trunk and arm and balance exercises that progress in difficulty; (4) five-minute cool down period (i.e. self-regulated walk). The exercise intensity will be assessed by one of the following criteria: 1) Resistance training - Point of volitional fatigue. Walking - Somewhat difficult (Borg at 3 to 4). The intensity will be increased according to the ACSM guideline. The exercise was set up based on changes in instruments of evaluation of the older peoples as, Berg Balance Scale; Dynamic Gait Index and Timed Up and Go. In addition, exercises commonly used in primary health care groups. The protocol will take place in a gymnasium and will be supervised by a trained instructor.

No Intervention: Control Group

Participants randomly allocated to the control group will remain on a waiting list. In addition, weekly contact will be made to ensure that they do not start treatment during the study protocol. After the end of the study, participants randomly allocated to the control group will receive the same intervention as the Group-Based Exercise.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of blinding the assessor [8 weeks from randomization]

    Feasibility of blinding will be assessed by asking the assessor two questions at the end of the follow-up assessment: Did you receive any information that indicated to you which group the participant was assigned to? How did you receive information about group assignment? Assessor's guess regarding group assignment group will be recorded for each participant. The responses will be coded as correct or incorrect guess. The frequency and relative rates of 'Yes' and 'No' as the answer to the first question will be computed, as will the frequency and relative rates of correct and incorrect guesses. Finally, reasons for guesses will be recorded as verbatim and reported.

  2. Eligibility and recruitment rates [8 weeks from randomization]

    Eligibility and recruitment rates

  3. Acceptability of random allocation to a treatment group [8 weeks from randomization]

    Outcome assessor will ask the participants if random allocation to one of the two treatment groups is acceptable to the participants. Responses will be recorded as 'Acceptable', 'Not acceptable' or 'No preference'. The frequencies of each response will be computed separately for each treatment condition.

  4. Understanding possible contamination between the groups [8 weeks from randomization]

    Measures to assess: Have you talked to other participants in this study about the intervention they are receiving? Has your attitude towards the intervention changed after talking to the participant (s) in the other group? Are any of the participants in the other group aware of the type of intervention you are receiving in this study? The frequencies of the participants who responded affirmatively to each question will be computed separately for each treatment condition.

  5. Adherence to treatment [8 weeks from randomization]

    Adherence to treatment measured by frequency during the intervention

  6. Satisfaction with the treatment [8 weeks from randomization]

    All the participants of the intervention group will be asked to respond an adapted version of the MedRisk Instrument for Measuring Patient Satisfaction With Physical Therapy Care at 1 week following treatment. The question asked will be: Did my physiotherapist carefully explain the treatments I received? Did my physiotherapist treat me respectfully? Did my physiotherapist answer all my questions? n general, am I completely satisfied with the services I received from my physical therapist? Responses to this question are made on a five-point categorical scale 1='completely disagree'; 2='Disagree'; 3= 'Neutral'; 4=' Agree'; 5=' Completely agree'). The frequency of response for each question will be analyzed

  7. Difficulty in understanding the information provided by the physiotherapist [8 weeks from randomization]

    Difficulty in understanding the information provided by the physiotherapist measured on a five-point categorical scale: Very easy, Easy, Neither easy nor difficult, Difficult, Very difficult

Secondary Outcome Measures

  1. Pain intensity [8 weeks from randomization]

    Pain intensity measured with a Numerical Rating Scale from 0 to 10, , where 0 does not cause pain and 10 is the worst pain imaginable.

  2. Disability [8 weeks from randomization]

    Disability measured with the Roland-Morris Disability Questionnaire. The questionnaire has 24 items with scores of 0 or 1 (yes or no) and the total ranges from zero (suggesting no disability) to 24 (severe disability).

  3. Fear of falling [8 weeks from randomization]

    Fear of falling measured with the Falls Efficacy Scale- International. The Falls Efficacy Scale - International presents questions about the concern with the possibility of falling when performing 16 activities, with respective scores from one to four. The total score can range from 16 (no concern) to 64 (extreme concern).

  4. Level of physical activity [8 weeks from randomization]

    Level of physical activity measured with the Physical Activity Rating scale. It is a progressive scale with scores from 0 to 7, in which the most appropriate option for the history of physical activity practice in the last 30 days should be selected.

  5. Global perception of recovery [8 weeks from randomization]

    Global perception of recovery measured with Global Effect Perception Scale. This is a numerical scale where -3 represents "worse than ever", 0 "without modification" and 3 "completely recovered". A higher score means greater recovery from the condition.

  6. Frequency of falls [8 weeks from randomization]

    Frequency of falls assessed by the number of falls during the study period

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Older people aged 60 years old or over who have nonspecific LBP, defined as pain below the costal margin and above the lower gluteal folds, with or without referred leg pain for at least 3 months.

  • Disability with score 4/24 in Roland-Morris Disability Questionnaire or higher and persistent back pain of pain 3/10 or higher.

Exclusion Criteria:
  • Suspected or confirmed serious spinal pathology (fracture, metastatic, inflammatory or infective diseases of the spine, cauda equina syndrome/widespread neurological disorder);

  • Radiculopathy (i.e. presence of 2 of the 3 following criteria: strength, reflex or sensation alterations compatible with lumbosacral nerve root compression);

  • Previous history of spinal surgery; scheduled for major surgery during the study or at the follow up period;

  • Any of the contraindications to exercise listed on page 103 of the American College of Sports Medicine (ACSM) guidelines.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Federal University of the Valleys of Jequitinhonha and Mucuri

Investigators

  • Principal Investigator: Letícia Soares Fonseca, Federal University of the Valleys of Jequitinhonha and Mucur

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Federal University of the Valleys of Jequitinhonha and Mucuri
ClinicalTrials.gov Identifier:
NCT04915547
Other Study ID Numbers:
  • 30042021
First Posted:
Jun 7, 2021
Last Update Posted:
Jun 7, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2021